Anticancer activity of tolfenamic acid in medulloblastoma: a preclinical study.
about
Combination of tolfenamic acid and curcumin induces colon cancer cell growth inhibition through modulating specific transcription factors and reactive oxygen speciesSmall molecule tolfenamic acid and dietary spice curcumin treatment enhances antiproliferative effect in pancreatic cancer cells via suppressing Sp1, disrupting NF-kB translocation to nucleus and cell cycle phase distributionTargeting specificity protein 1 transcription factor and survivin using tolfenamic acid for inhibiting Ewing sarcoma cell growth.
P2860
Anticancer activity of tolfenamic acid in medulloblastoma: a preclinical study.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Anticancer activity of tolfenamic acid in medulloblastoma: a preclinical study.
@en
Anticancer activity of tolfenamic acid in medulloblastoma: a preclinical study.
@nl
type
label
Anticancer activity of tolfenamic acid in medulloblastoma: a preclinical study.
@en
Anticancer activity of tolfenamic acid in medulloblastoma: a preclinical study.
@nl
prefLabel
Anticancer activity of tolfenamic acid in medulloblastoma: a preclinical study.
@en
Anticancer activity of tolfenamic acid in medulloblastoma: a preclinical study.
@nl
P2093
P2860
P1433
P1476
Anticancer activity of tolfenamic acid in medulloblastoma: a preclinical study
@en
P2093
Liz Abraham
Pius Maliakal
Riyaz Basha
P2860
P2888
P304
P356
10.1007/S13277-013-0836-6
P577
2013-05-18T00:00:00Z